These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 18303540)

  • 21. [Primary laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ-cell testis tumor].
    Castillo OA; Sánchez-Salas R; Secin FP; Campero JM; Foneron A; Vidal-Mora I
    Actas Urol Esp; 2011 Jan; 35(1):22-8. PubMed ID: 21256391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome.
    Janetschek G; Hobisch A; Peschel R; Hittmair A; Bartsch G
    J Urol; 2000 Jun; 163(6):1793-6. PubMed ID: 10799184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
    Yoon GH; Stein JP; Skinner DG
    Urol Oncol; 2005; 23(3):168-77. PubMed ID: 15907716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.
    Foster RS; Donohue JP
    J Urol; 2000 Jun; 163(6):1788-92. PubMed ID: 10799183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications.
    Permpongkosol S; Lima GC; Warlick CA; Allaf ME; Varkarakis IM; Bagga HS; Kohanim S; Kavoussi LR
    Urology; 2007 Feb; 69(2):361-5. PubMed ID: 17320678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic laparoscopic retroperitoneal lymph node dissection for non seminomatous testicular tumor.
    Janetschek G; Reissigl A; Peschel R; Hobisch A; Bartsch G
    Ann Urol (Paris); 1995; 29(2):81-90. PubMed ID: 7646002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
    Steiner H; Peschel R; Janetschek G; Höltl L; Berger AP; Bartsch G; Hobisch A
    Urology; 2004 Mar; 63(3):550-5. PubMed ID: 15028456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer.
    Nielsen ME; Lima G; Schaeffer EM; Porter J; Cadeddu JA; Tuerk I; Kavoussi LR
    Urology; 2007 Dec; 70(6):1168-72. PubMed ID: 18158040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Tal R; Sheinfeld J
    J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status.
    Bhayani SB; Allaf ME; Kavoussi LR
    Urol Oncol; 2004; 22(2):145-8. PubMed ID: 15082014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic retroperitoneal lymph node dissection.
    Janetschek G
    Arch Esp Urol; 2002; 55(6):629-36. PubMed ID: 12224161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.
    Nicolai N; Colecchia M; Biasoni D; Catanzaro M; Stagni S; Torelli T; Necchi A; Piva L; Milani A; Salvioni R
    J Urol; 2011 Oct; 186(4):1298-302. PubMed ID: 21849196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robotic-assisted laparoscopic retroperitoneal lymph node dissection.
    Davol P; Sumfest J; Rukstalis D
    Urology; 2006 Jan; 67(1):199. PubMed ID: 16413370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nine cases of laparoscopic retroperitoneal lymph node dissection].
    Yang JG; Günter J; Huang DL; Fang LK
    Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):534-6. PubMed ID: 12921663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
    J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study.
    Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Becht E
    Urology; 2006 Jul; 68(1):154-60. PubMed ID: 16820195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
    Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
    Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.